Allegheny Health Network Cancer Institute

Pittsburgh, Pennsylvania 15224

2 studies enrolling now · 5 studies all time

What they study most

Central Nervous System Lymphoma, Glioblastoma Multiforme, Graft-versus-host Disease (GVHD), High Grade B-cell Lymphoma (HGBCL), Malignant Ascites, Malignant Pleural Effusion, Mantle Cell Lymphoma (MCL), Metastatic Breast Cancer, Primary Mediastinal B-cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, Richter Transformation

Studies at this site

• DALY II USA/ MB-CART2019.1 for DLBCL — Recruiting now
• Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer — Recruiting now
• Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins — Running, not enrolling
• Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM — Completed
• An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant — APPROVED_FOR_MARKETING